(S)-2-(2-BROMOPHENYL)-4-ISOPROPYL-4,5-DIHYDROOXAZOLE, 95%, 250mg

4-(5-Phenyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide, 98%, 10mg

1,2,3,4-Tetrahydro-naphthalene-2-carboxylic acid, 95.0%, 5g

(2S,4R)-1-[(2S)-2-[(1-cyanocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide, 98%, 100mg

5'-Phenyl-1,1':3',1''-terphenyl, 95.0%, 100g

(S)-2-(6-Benzylpyridin-2-yl)-4-(tert-butyl)-4,5-dihydrooxazole, 97%, 1g

2-Amino-5-methylbenzoic acid, 97.0%, 1kg

1'H-Spiro[piperidine-4,4'-quinazolin]-2'(3'H)-one, 95.0%, 250mg

2-Bromo-4,6-difluoronitrobenzene, 95.0%, 10g

4-Methoxy-2,6-dimethylaniline, 95.0%, 10g

2-(2,4-Dichloro-phenoxy)acetonitrile, 97.0%, 1g

(2-(4-Methylpiperazin-1-yl)phenyl)methanamine, 95.0%, 1g

TETRAKIS(DIMETHYLAMINO)ETHYLENE, 95%, 5g